Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.03T
Market cap1.03T
Price-Earnings ratio
40.03
Price-Earnings ratio40.03
Dividend yield
0.58%
Dividend yield0.58%
Average volume
3.26M
Average volume3.26M
High today
$1,125.59
High today$1,125.59
Low today
$1,088.66
Low today$1,088.66
Open price
$1,118.67
Open price$1,118.67
Volume
4.47M
Volume4.47M
52 Week high
$1,182.73
52 Week high$1,182.73
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.03T, Eli Lilly(LLY) trades at $1,099.05. The stock has a price-to-earnings ratio of 40.03 and currently yields dividends of 0.58%.

On 2026-06-19, Eli Lilly(LLY) stock moved within a range of $1,088.66 to $1,125.59. With shares now at $1,099.05, the stock is trading +1.0% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 4.47M, compared to an average daily volume of 3.26M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

LLY News

The Motley Fool 53m
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own

Eli Lilly (LLY 1.16%) and Twist Bioscience (TWST +5.66%) are two healthcare companies using AI in very different ways, but with the same goal: speeding up real-...

The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
Barron's 4h
Under Dave Ricks, Lilly Is Minting Money on GLP-1 Drugs and Spending It Wisely - Barron's

...

Under Dave Ricks, Lilly Is Minting Money on GLP-1 Drugs and Spending It Wisely - Barron's
Simply Wall St 10h
Eli Lilly Expands TuneLab As It Builds Pain And Cancer Pipeline

Eli Lilly (NYSE:LLY) is expanding its TuneLab AI drug discovery platform through new collaborations with Charles River Laboratories and Chai Discovery. The com...

Eli Lilly Expands TuneLab As It Builds Pain And Cancer Pipeline

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
9.4%
Sell
6.3%

More LLY News

TipRanks 17h
Lilly’s Lepodisiran Trial Targets Lp(a) as a New Front in Heart Risk

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 17h
Retatrutide Trial Completion Signals Next Step for Eli Lilly’s Diabetes Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

The Motley Fool 19h
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

After four trading days of selling -- outside of getting in on last week's record-setting initial public offering (IPO) -- Ark Invest co-founder, CEO, and Chief...

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The Motley Fool 23h
Vanguard vs VanEck: Which Healthcare ETF Is the Better Buy?

Vanguard Health Care ETF (VHT 1.13%) provides broad-spectrum medical sector exposure at a low cost, while VanEck Pharmaceutical ETF (PPH 0.81%) offers concentra...

Vanguard vs VanEck: Which Healthcare ETF Is the Better Buy?
TipRanks 1d
Cathie Wood’s ARK Investment buys 41K shares of Eli Lilly today

20:31 EDT Cathie Wood’s ARK Investment buys 41K shares of Eli Lilly (LLY) today Published first on TheFly – the ultimate source for real-time, market-moving br...

TipRanks 2d
Lilly’s TOGETHER-PsO Trial: A New Push To Link Psoriasis And Obesity Treatment

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 3d
M&A News: Eli Lilly Expands Into Painkiller Market with Latest Acquisition

Eli Lilly (LLY) is expanding into the market for non-addictive painkillers with its latest acquisition. Unlock powerful investing tools and data-driven insight...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.